EyePoint Pharmaceuticals Statistics
Total Valuation
EYPT has a market cap or net worth of $585.84 million. The enterprise value is $397.60 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
EYPT has 70.16 million shares outstanding. The number of shares has increased by 34.50% in one year.
| Current Share Class | 70.16M |
| Shares Outstanding | 70.16M |
| Shares Change (YoY) | +34.50% |
| Shares Change (QoQ) | +2.34% |
| Owned by Insiders (%) | 0.67% |
| Owned by Institutions (%) | 60.34% |
| Float | 48.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.93 |
| Forward PS | 15.12 |
| PB Ratio | 2.19 |
| P/TBV Ratio | 2.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.50, with a Debt / Equity ratio of 0.11.
| Current Ratio | 5.50 |
| Quick Ratio | 5.21 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -74.68% and return on invested capital (ROIC) is -47.18%.
| Return on Equity (ROE) | -74.68% |
| Return on Assets (ROA) | -31.39% |
| Return on Capital (ROIC) | -47.18% |
| Revenue Per Employee | $377,793 |
| Profits Per Employee | -$855,950 |
| Employee Count | 121 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 29.85 |
Taxes
In the past 12 months, EYPT has paid $83,000 in taxes.
| Income Tax | 83,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.66% in the last 52 weeks. The beta is 1.52, so EYPT's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +19.66% |
| 50-Day Moving Average | 9.77 |
| 200-Day Moving Average | 13.56 |
| Relative Strength Index (RSI) | 36.40 |
| Average Volume (20 Days) | 1,298,270 |
Short Selling Information
The latest short interest is 9.68 million, so 13.80% of the outstanding shares have been sold short.
| Short Interest | 9.68M |
| Short Previous Month | 9.17M |
| Short % of Shares Out | 13.80% |
| Short % of Float | 19.87% |
| Short Ratio (days to cover) | 10.40 |
Income Statement
In the last 12 months, EYPT had revenue of $45.71 million and -$103.57 million in losses. Loss per share was -$2.04.
| Revenue | 45.71M |
| Gross Profit | -64.49M |
| Operating Income | -115.77M |
| Pretax Income | -86.74M |
| Net Income | -103.57M |
| EBITDA | -114.58M |
| EBIT | -115.77M |
| Loss Per Share | -$2.04 |
Full Income StatementBalance Sheet
The company has $253.79 million in cash and $23.11 million in debt, giving a net cash position of $230.68 million or $3.29 per share.
| Cash & Cash Equivalents | 253.79M |
| Total Debt | 23.11M |
| Net Cash | 230.68M |
| Net Cash Per Share | $3.29 |
| Equity (Book Value) | 218.73M |
| Book Value Per Share | 4.09 |
| Working Capital | 219.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$113.49 million and capital expenditures -$4.55 million, giving a free cash flow of -$118.04 million.
| Operating Cash Flow | -113.49M |
| Capital Expenditures | -4.55M |
| Free Cash Flow | -118.04M |
| FCF Per Share | -$1.68 |
Full Cash Flow StatementMargins
Gross margin is -141.06%, with operating and profit margins of -253.25% and -226.57%.
| Gross Margin | -141.06% |
| Operating Margin | -253.25% |
| Pretax Margin | -226.38% |
| Profit Margin | -226.57% |
| EBITDA Margin | -250.66% |
| EBIT Margin | -253.25% |
| FCF Margin | -187.25% |
Dividends & Yields
EYPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.50% |
| Shareholder Yield | -34.50% |
| Earnings Yield | -17.68% |
| FCF Yield | -20.15% |
Analyst Forecast
The average price target for EYPT is $27.29, which is 226.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.29 |
| Price Target Difference | 226.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 47.30% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 9, 2020. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Dec 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
EYPT has an Altman Z-Score of 0.99 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.99 |
| Piotroski F-Score | 1 |